Approval · Notice of Compliance 13064 · 2012
RESPIPULMIN: Notice of Compliance 13064
Issued February 28, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13064
- Date
- February 28, 2012
- Company
- Modern Veterinary Therapeutics LlcSunrise, Florida, United States
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Bronchodilator
- Canadian reference product
- VENTIPULMIN (Boehringer Ingelheim (Canada) Ltd.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RESPIPULMIN | 02380803 | Marketed |
Medicinal ingredients
- CLENBUTEROL HCL 0.025 MG per ML